Lotte Ørneborg Rodkjær

Lotte Ørneborg Rodkjær

Auto-generated profile, based on publicly available information

Lotte Ørneborg Rodkjær

Research Centre for Patient Involvement (ResCenPI), Aarhus University and Aarhus University Hospital Aarhus Denmark

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2009 in HIV Medicine
Verified
Journal Article
Open access
PDF file
LRL Rodkjaer
L Rodkjaer
TLT Laursen
T Laursen
NBN Balle
N Balle
MSM Sodemann
M Sodemann
Background: International studies suggesting that 20–37% of HIV‐positive patients have diagnosable depression may underestimate the prevalence of this condition. The aim of this study was to investigate the prevalence of depression among HIV‐positive patients in an out‐patient clinic in Denmark and to detect factors of importance for the development of depression.Methods: In 2005, a population of 205 HIV‐positive patients was included in a questionnaire‐based study. The Beck Depression Inventory II (BDI‐II) was used to assess the prevalence and severity of depressive symptoms. Patients with a BDI score of 20 or above were offered a clinical evaluation by a consultant psychiatrist.Results: Symptoms of depression (BDI>14) were observed in 77 (38%) patients and symptoms of major depression (BDI≥20) in 53 (26%). Eighteen patients subsequently started treatment with anti‐depressants. In a reduced logistic regression model, self‐reported stress, loneliness, constant thoughts about HIV and being in a difficult financial situation were associated with risk of depression. Patients at risk of major depression were nearly six times more likely to have missed at least one dose of highly active antiretroviral therapy (HAART) in the 4 days prior to assessment (odds ratio 5.7, 95% confidence interval 1.7–18.6). There was a dose–response trend in relation to unsafe sex (P=0.03).Conclusions: The study found that depression was under‐diagnosed among HIV‐positive patients and was associated with stress, loneliness, a difficult financial situation, low adherence and unsafe sex. Screening for depression should be conducted regularly to provide full evaluation and relevant psychiatric treatment. This is particularly important at the time of diagnosis and before initiating HAART.

1 May 2014 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
LRL. Rodkjaer
L. Rodkjaer
MCM.A. Chesney
M.A. Chesney
KLK. Lomborg
K. Lomborg
LOL. Ostergaard
L. Ostergaard
TLT. Laursen
T. Laursen
MSM. Sodemann
M. Sodemann
Having effective ways to cope helps HIV-infected individuals maintain good psychological and physical well-being. This study investigated the relationship between coping self-efficacy levels, as determined by the Coping Self-Efficacy Scale (CSE), HIV status disclosure, and depression in a Danish cohort. In 2008, the CSE was administered to 304 HIV-infected individuals to measure their confidence in their ability to cope with HIV infection. HIV status disclosure was assessed on a three-point scale: living openly with the disease, partly openly, or secretly. The Beck Depression Inventory (BDI) was used to assess depression prevalence and severity. The CSE score was significantly related to depression (Spearman's rho = -0.71; the test of H0: BDI and coping, probability >t=0.0001). There was a significant relationship between higher CSE scores and living openly with HIV. The risk of depression was four times higher in HIV-infected individuals who did not disclose their HIV status (i.e. who lived 'secretly'; odds ratio = 4.1) than in individuals who lived openly. Those with low CSE scores were more likely to report living secretly with HIV and to be depressed. Disclosing HIV may constitute a social stressor, and a lack of coping self-efficacy may increase the likelihood of non-disclosure and depression. Interventions that enhance self-efficacy may help in managing the demands of daily life with HIV, increase disclosure, and reduce depression.

26 August 2022 in Research Involvement and Engagement
Verified
Journal Article
Open access
PDF file
JFJeanette Finderup
Jeanette Finderup
LBLouise Engelbrecht Buur
Louise Engelbrecht Buur
STSarah Cecilie Tscherning
Sarah Cecilie Tscherning
AJAnnesofie Lunde Jensen
Annesofie Lunde Jensen
AKAnne Wilhøft Kristensen
Anne Wilhøft Kristensen
LRLotte Ørneborg Rodkjær
Lotte Ørneborg Rodkjær
Background: Although interest in Patient and Public Involvement in health-related research is growing, there seems to be a lack of guidance supporting researchers in deciding on methods and levels for Patient and Public Involvement in health-related research throughout the research process. Furthermore, the numerous definitions, methods, and frameworks make it challenging for researchers new to this field to decide on the most appropriate approach for their project. Methods: This study aimed to develop and test guidance for researchers deciding on approaches, levels, and methods for engaging patient partners in health-related research. A group of 11 researchers in Patient and Public Involvement in health-related research participated in six workshops to develop the guidance. The feasibility and acceptability of the guidance were tested in a survey of 14 researchers using the System Usability Scale plus two elaborative questions. The guidance was also tested by five PhD students engaging patient partners in their projects. Results: The guidance developed consisted of two resources: Resource I outlined five international approaches to Patient and Public Involvement in health-related research, and Resource II described the different levels and methods for engaging patient partners in research. The System Usability Scale score (at the 50th percentile) was 80, indicating excellent usability. Qualitative data showed that the two resources supported reflections regarding different approaches, levels, and methods. Conclusion: The researchers found the guidance to be supportive of their reflective thinking about engaging patient partners in their research. The testing provided knowledge about when and how to use the guidance but also raised questions about the usefulness of the guidance in communications with patients.

11 April 2011 in Qualitative Health Research
Verified
Journal Article
Closed access
PDF file
LRLotte Rodkjaer
Lotte Rodkjaer
MSMorten Sodemann
Morten Sodemann
LOLars Ostergaard
Lars Ostergaard
KLKirsten Lomborg
Kirsten Lomborg
The purpose of this grounded theory study was to investigate how Danish HIV-positive persons live with their disease, focusing on HIV-related stressors. Using the Glaserian method, we analyzed textual data from in-depth interviews with 16 HIV-positive persons. Decisions about disclosure appeared to be a major concern and a determining factor for HIV-related stress. Consequently, we developed a substantive theory about disclosure decisions in which three different strategies could be identified: (a) disclosing to everyone (being open); (b) restricting disclosure (being partly open); and (c) disclosing to no one (being closed). Disclosure was a continuum; none of the three strategies automatically relieved HIV-related stress. The theory describes the main determinants and consequences of each strategy. Our study demonstrates the importance of recurrent individual considerations about disclosure choices and plans, and offers a theoretical basis for interventions designed to assist persons living with HIV to make the best possible individual decisions regarding disclosure, and thereby reduce HIV-related stress.

8 July 2025 in Research Involvement and Engagement
Verified
Journal Article
Open access
PDF file
STSarah Cecilie Tscherning
Sarah Cecilie Tscherning
AJAnnesofie Lunde Jensen
Annesofie Lunde Jensen
HBHilary Louise Bekker
Hilary Louise Bekker
TVTina Wang Vedelø
Tina Wang Vedelø
JFJeanette Finderup
Jeanette Finderup
LRLotte Ørneborg Rodkjaer
Lotte Ørneborg Rodkjaer
Including patients and next of kin as partners in research can help promote the development and dissemination of results that are inclusive, usable and relevant to health service settings. However, the impact of such involvement remains largely anecdotal, necessitating research to identify methods for achieving meaningful involvement. The aim was to examine how patient partners are involved in research across health service settings by addressing three objectives: (1) How are patient partners involved in the research process? (2) What is the impact of involving patient partners in research? (3) What defines effective patient partner involvement in research? We conducted a scoping review by searching five databases (Embase, Scopus, MEDLINE, CINAHL, PsycINFO) and grey literature. Published reviews within health service settings examining patient partner involvement were included. Protocol papers and reviews on patient involvement in treatment and care were excluded. The review adhered to Arksey and O’Malley’s methodological framework and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Checklist. A total of 124 reviews were included. Most reviews have been published after 2014, primarily from the United Kingdom, Canada and the United States of America. Patient partners were involved with consultation and collaboration approaches in different stages of the research process, including identifying and prioritising (n = 49), designing (n = 57), managing (n = 40), undertaking (n = 53) and disseminating (n = 51) and less in commissioning (n = 11), implementing (n = 6) and evaluating impact (n = 17). Impact reporting varied, with few reviews (n = 11) explicitly defining ‘impact’ and its related concepts. Sixteen key enablers for effective patient partner involvement were identified. The most reported enablers included partnerships built on trust and inclusive communication (n = 56), training and support for patient partners (n = 53), flexibility (n = 48) and adequate resources (n = 45). A significant gap exists in defining and measuring patient partner involvement. Adequate resources and training are essential for furthering trust-based, inclusive partnerships between researchers and patient partners. Future research should prioritise improving impact assessment, addressing power imbalances and refining best practices to enhance effective involvement. Two authors contributed with lived experience as patients and next of kin. Four patient partners were consulted about the results, one of whom coauthored this scoping review. Patients and next of kin are encouraged to participate in planning, conducting and evaluating research studies. This involvement can generate more diverse, usable and valid research results. However, what constitutes ‘good enough’ involvement has not been thoroughly investigated. We aim to describe how patients and next of kin can be involved in research by answering three main objectives: (1) How are patient partners and next of kin involved in research? (2) How does involvement change the research? (3) What makes patient involvement in research work well? We carried out a scoping review, a type of research that maps out what has been studied so far, to summarise how researchers report involving patient partners in their studies and how this involvement affects the quality of the studies. We looked at 124 reviews. Most of the reviews were published in the United Kingdom, Canada, and the United States of America. Patients and next of kin take part in different research, mostly by giving advice or working closely with researchers. However, most reviews did not define what impact or related terms mean. Most also pointed out that researchers do not report clearly how patient involvement makes a difference. Sixteen enablers were found to foster the effective involvement of patient partners. In short, good teamwork based on trust, clear communication, and enough funding, training, and support is key to making patient involvement work well. We suggest that future research should create better guidelines to support effective involvement and find ways to measure its impact.

14 November 2021 in Journal of Cystic Fibrosis
Verified
Journal Article
Open access
LRLotte Rodkjær
Lotte Rodkjær
MJMajbritt Jeppesen
Majbritt Jeppesen
LSLiv Schougaard
Liv Schougaard
Patients with cystic fibrosis (CF) are considered to be a COVID-19 risk group. In March 2020, a fast-track Patient Reported Outcome (PRO) solution was developed to ensure access to CF care without in-person hospital visits. This study investigated the feasibility of urgently replacing in-person appointments with remote monitoring using telephone consultations combined with PROs. We investigated patients and health care professionals' (HCPs) acceptance, recruitment rate, response rate, missing data, and attrition. We included adult CF patients from the Department of Infectious Diseases at Aarhus University Hospital, Denmark between April and June 2020. Patients filled in a disease-specific questionnaire including relevant clinical aspects, performed home spirometry, and sent in a sputum sample before a scheduled telephone consultation. Twelve participants who completed the questionnaire and had a telephone consultation were interviewed. Three physicians and three nurses from the CF clinical team participated in a focus group interview. Eighty patients were recruited for remote monitoring, and 41 patients filled in at least one questionnaire. Overall, both patients and HCPs found remote monitoring and use of PROs acceptable and useful. Patients experienced greater flexibility and found the questionnaire relevant and understandable but pointed out the need for items regarding mental health status and more adequate information about changes in follow-up and workflow. Urgent reorganization of outpatient follow-up among CF patients due to COVID-19 was feasible in routine clinical practice. However, patient involvement should be a future point of attention to ensure a sustainable telehealth PRO solution.